ClinConnect ClinConnect Logo
Search / Trial NCT05870930

Bioavailability Study of Cretan Carob

Launched by HAROKOPIO UNIVERSITY · May 12, 2023

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Carob Phenolic Compound Bioavailability Metabolites Bioavailability In Humans Imera Carob

ClinConnect Summary

This clinical trial is studying how well the body absorbs certain healthy compounds found in a drink made from Cretan carob powder, specifically from a variety called Imera. The researchers want to see how these compounds behave in healthy men after they consume the beverage. This study is currently looking for participants who are male, between the ages of 65 and 74, and have normal body fat.

To join the study, potential participants should be healthy and not have conditions like obesity, diabetes, heart disease, or any significant liver or kidney problems. They also should not be taking supplements for weight loss or be dietitians/nutritionists. If eligible, participants can expect to drink the carob beverage and provide feedback on their experience. This study aims to better understand the health benefits of carob and how it can fit into a healthy diet.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • healthy male adults
  • normal body fat mass
  • Exclusion Criteria:
  • obesity (according to body fat mass)
  • Type 1 Diabetes, cardiovascular diseases, hypertension
  • thyroid disorder, liver disease, kidney disease
  • gastrointestinal disease
  • mental illness
  • use of nutraceutical supplements or natural products for weight loss
  • dietitians/nutritionists

About Harokopio University

Harokopio University, located in Athens, Greece, is a prominent academic institution dedicated to advancing research and education in various fields, including health sciences and nutrition. With a strong commitment to interdisciplinary collaboration, the university actively engages in clinical trials aimed at exploring innovative solutions to pressing health challenges. Through its rigorous research programs and partnerships with healthcare professionals, Harokopio University strives to contribute valuable insights to the scientific community and improve public health outcomes.

Locations

Athens, , Greece

Patients applied

0 patients applied

Trial Officials

Andriana C Kaliora

Principal Investigator

Harokopio University of Athens, Greece

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported